Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (1): 150-157.doi: 10.13481/j.1671-587X.20230119
• Research in clinical medicine • Previous Articles Next Articles
Yanya CHEN,Jinlan ZHAO,Chan LI,Lishan HUANG(
)
Received:2022-03-29
Online:2023-01-28
Published:2023-02-03
Contact:
Lishan HUANG
E-mail:2642387802@qq.com
CLC Number:
Yanya CHEN,Jinlan ZHAO,Chan LI,Lishan HUANG. Expression of miR-223 in ovarian cancer tissue and its promoting effect on proliferation and invasion of ovarian cancer OVCAR3 cells[J].Journal of Jilin University(Medicine Edition), 2023, 49(1): 150-157.
Tab.1
Expression levels of miR-223 in cancer tissue of ovarian cancer patients with different clinicopathological features"
| Clinicopathological feature | n | MiR-223 | t | P |
|---|---|---|---|---|
| Age(year) | 0.982 | 0.331 | ||
| <50 | 18 | 4.02±2.26 | ||
| ≥50 | 27 | 4.82±2.90 | ||
| Tumor size(d/cm) | 0.599 | 0.552 | ||
| <5 | 21 | 4.25±2.42 | ||
| ≥5 | 24 | 4.73±2.90 | ||
| Histological differentiation | 2.812 | 0.007 | ||
| Medium/high | 28 | 3.69±2.35 | ||
| Low | 17 | 5.84±2.69 | ||
| FIGO stage | 5.355 | <0.001 | ||
| Ⅰ-Ⅱ | 22 | 2.80±1.57 | ||
| Ⅲ-Ⅳ | 23 | 6.13±2.49 | ||
| Lymph node metastasis | 3.505 | 0.001 | ||
| No | 26 | 3.44±2.39 | ||
| Yes | 19 | 5.96±2.37 |
| 1 | SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30. |
| 2 | ARTS F A, KEOGH L, SMYTH P, et al. miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma[J]. Hum Pathol, 2017, 70: 98-104. |
| 3 | ARTS F A, KEOGH L, SMYTH P, et al. MiR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma[J]. Hum Pathol, 2017, 70: 98-104. |
| 4 | ZHU X L, SHEN H L, YIN X M, et al. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype[J]. J Exp Clin Cancer Res, 2019, 38(1): 81. |
| 5 | LIM S C, GELETA B, MALEKI S, et al. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer[J]. J Biol Chem, 2021, 297(6): 101414. |
| 6 | QUAN Y J, ZHANG X D, BUTLER W, et al. The role of N-cadherin/c-Jun/NDRG1 axis in the progression of prostate cancer[J]. Int J Biol Sci, 2021, 17(13): 3288-3304. |
| 7 | WANG J Y, LV W Z, LIN Z D, et al. Hsa_circ_0003159 inhibits gastric cancer progression by regulating miR-223-3p/NDRG1 axis[J]. Cancer Cell Int, 2020, 20: 57. |
| 8 | GIANNOPOULOU L, ZAVRIDOU M, KASIMIR-BAUER S, et al. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes[J]. Transl Res, 2019, 205: 77-91. |
| 9 | YANG L, MA H L. MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1[J]. Eur Rev Med Pharmacol Sci, 2020, 24(3): 1062-1071. |
| 10 | YANG N, ZHANG Q, BI X J. MiRNA-96 accelerates the malignant progression of ovarian cancer via targeting FOXO3a[J]. Eur Rev Med Pharmacol Sci, 2020, 24(1): 65-73. |
| 11 | DUNAEVA M, BLOM J, THURLINGS R, et al. Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis[J]. Clin Exp Immunol, 2018, 193(3): 376-385. |
| 12 | WU Z M, LUO J, SHI X D, et al. Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis[J]. Autoimmunity,2020,53(8): 450-458. |
| 13 | ROFFEL M P, BRACKE K R, HEIJINK I H, et al. miR-223: a key regulator in the innate immune response in asthma and COPD[J]. Front Med (Lausanne), 2020, 7: 196. |
| 14 | ZHANG D, LEE H, WANG X Y, et al. A potential role of microvesicle-containing miR-223/142 in lung inflammation[J]. Thorax, 2019, 74(9): 865-874. |
| 15 | DING Q P, SHEN L, NIE X H, et al. miR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas[J]. Pathol Res Pract, 2018, 214(9): 1330-1339. |
| 16 | XIAO W, WANG X G, WANG T, et al. miR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma[J].Aging (Albany NY),2019,11(2): 615-633. |
| 17 | YANG Z P, LU S, WANG Y Y, et al. A novel defined necroptosis-related miRNAs signature for predicting the prognosis of colon cancer[J]. Int J Gen Med, 2022, 15: 555-565. |
| 18 | JIN X L, QIU X, HUANG Y, et al. miR-223-3p carried by cancer-associated fibroblast microvesicles targets SORBS1 to modulate the progression of gastric cancer[J]. Cancer Cell Int, 2022, 22(1): 96. |
| 19 | CHANG X J, XU X Y, XUE X Y, et al. NDRG1 controls gastric cancer migration and invasion through regulating MMP-9[J]. Pathol Oncol Res, 2016, 22(4): 789-796. |
| 20 | NAKAHARA Y, ITO H, NAMIKAWA H, et al. A tumor suppressor gene, N-myc downstream-regulated gene 1 (NDRG1), in gliomas and glioblastomas[J]. Brain Sci, 2022, 12(4): 473. |
| 21 | PARK K C, PALUNCIC J, KOVACEVIC Z, et al. Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer[J]. Free Radic Biol Med, 2020, 157: 154-175. |
| 22 | GELETA B, TOUT F S, LIM S C, et al. Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1[J]. J Biol Chem, 2022, 298(3): 101608. |
| 23 | QUAN Y J, CUI Y, WAHAFU W, et al. MLL5α activates AR/NDRG1 signaling to suppress prostate cancer progression[J]. Am J Cancer Res, 2020, 10(5): 1608-1629. |
| 24 | DE LIMA J M, MORAND G B, MACEDO C C S,et al.NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition[J].Carcinogenesis,2020,41(6): 769-777. |
| [1] | Xiao ZHOU,Haitao DAI,Yunshan DING,Linjie ZHANG,Nan WU. Network pharmacology analysis and in vitro experimental validation of anticancer effect of grape seed proanthocyanidins against oral squamous cell carcinoma [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 651-662. |
| [2] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [3] | Yao ZHENG,Mingxia FU,Weichen WANG,Weiwei CHEN,Yuchen HAN,Yu BAI,Jiajia AN. Effect of sodium selenite on biological behaviors of breast cancer doxorubicin-resistant MCF-7/ADR cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 410-417. |
| [4] | Li ZHAI,Meng CHEN,Jianbo LUO,Aili ZHANG,Liangxiao WANG,Ying WEI,Xi ZHANG. Targeting relationship between miR-214-3p and EZH2 and its effects on proliferation, invasion, and apoptosis of ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 460-468. |
| [5] | Hong LI,Panpan YU,Zouyu ZHAO,Chongfeng SUN,Hui QIAO,Ping YANG. Expression of GSTO1 in ovarian cancer tissue and effect of N-glycosylation site mutations on biological behaviors of epithelial ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 469-482. |
| [6] | Yunshan DING,Haitao DAI,Min CHEN,Xiaohui HAO,Xiao ZHOU,Nan WU. Effect of silencing TRPV2 gene and cannabidiol on biological behaviors of oral squamous cell carcinoma CAL-27 cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 143-151. |
| [7] | Yan ZHAO,Huawei WU. Inhibitory effect of inhibition of miR-17-5p on proliferation of spinal cord astrocytes of rats induced by scratch injury through targeting Mfn2 expression [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 81-92. |
| [8] | Xiaohan YAO,Mingchen YAO,Zhiqing WANG,Heyang LI,Yan YAN,Ningjing LEI. Effect of silencing GPR139 gene on proliferation, apoptosis and autophagy of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 1-9. |
| [9] | Sifan FENG,Yunfeng LI,Jiaying WANG,Fubin MA,Yan WANG. Effects of heme-binding protein 1 gene knockdown on proliferation, migration, and inflammatory response of microglia BV2 and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1532-1541. |
| [10] | Lulu FU,Yinggang ZOU,Xiaoyu ZHENG,Xueying ZHANG,Jingshun ZHANG,Min WANG,Qiang ZHANG,Lianwen ZHENG. Expression of placenta expressed transcription factor 1 in ovarian tissue of polycystic ovary syndrome rats and its effect on proliferation of rat ovarian granulosa cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1177-1184. |
| [11] | Pingsheng ZHU,Sitang GE,Lugen ZUO,Deli CHEN,Yangyang ZHANG. Effect of miR-325-3p targeting PRELID1 gene in regulation of EMT pathway on invasion and migration of colon cancer cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1185-1193. |
| [12] | Zhongjun SHEN,Yao ZHAO,Mingbo JIA,Liyan ZHAO. Research progress in effects of hypoxia-inducible factors on cell migration and invasion during epithelial-mesenchymal transition in glioma cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1145-1154. |
| [13] | Yixuan GAO,Peng WANG,Silong ZHANG,Ruijuan GAO,Yingfang MA,Keke ZHANG,Dan FENG,Zongqi HUANG,Ketao MA,Li LI,Junqiang SI. Inhibitory effect of safranal on proliferation, migration and phenotypic transformation of vascular smooth muscle cells of rats induced by high glucose in vitro [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 948-957. |
| [14] | Xiaoshuang HE,Lina XU,Mei CUI,Yu ZHAO,Bei WANG,Zheng HUANG,Yuchao WANG,Wenyan XIN,Chao WU. Effects of lncRNA DUXAP8 in lung cancer A549 cells-derived exosomes on lung cancer cell growth and its mechnism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 958-967. |
| [15] | Hongli LI,Mengyao WANG,Yangyang LIU,Hui ZHANG,Li LI. Effect of KHSRP on biological behavior of colorectal cancer cells through activation of JAK/STAT signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 996-1006. |